You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Patent: 8,586,045

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,586,045

Title:	Methods of using anti-CGRP antagonist antibodies
Abstract:	The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
Inventor(s):	Zeller; Joerg (Ann Arbor, MI), Poulsen; Kristian T. (San Francisco, CA), Abdiche; Yasmina Noubia (Mountain View, CA), Pons; Jaume (San Bruno, CA), Collier; Sierra Lee Jones (Menlo Park, CA), Rosenthal; Arnon (Woodside, CA)
Assignee:	Labrys Biologics, Inc. (San Mateo, CA)
Application Number:	13/179,846
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,586,045
Patent Claims:	see list of patent claims

Details for Patent 8,586,045

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Teva Branded Pharmaceutical Products R&d, Inc.	AJOVY	fremanezumab-vfrm	Injection	761089	09/14/2018	⤷ Try a Trial	2025-11-14
Teva Branded Pharmaceutical Products R&d, Inc.	AJOVY	fremanezumab-vfrm	Injection	761089	01/27/2020	⤷ Try a Trial	2025-11-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 8,586,045

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Australia	2006313434	⤷ Try a Trial
Brazil	PI0618705	⤷ Try a Trial
Canada	2626120	⤷ Try a Trial
China	101309704	⤷ Try a Trial
China	103421114	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.